About Vmg pharmaceuticals
Vmg pharmaceuticals is a Healthcare company based in Gurugram (India) founded in 2008. Manufacturing and exporting of pharmaceutical products across therapeutic segments in India. Its Indian entity Vmg Pharmaceuticals Private Limited reported revenue of ₹2.17 Cr. Vmg pharmaceuticals offers products and services including Trientine Hydrochloride and ATGAM Sterile Solution. Its focus areas include Pharmaceuticals, Drug Manufacturing, Specialty Medications and Export and Distribution.
Company details
VMG Pharmaceuticals Pvt. Ltd. was established in May 2008 in New Delhi, India, as part of VMG Healthcare Products S.A., which was founded in 1998 and headquartered in Costa Rica. A wide range of pharmaceutical products is offered across various therapeutic segments, with a strong international presence maintained across multiple geographies. Strong logistics and regulatory systems are provided in India, supporting global operations. The company is involved in hiring for key roles to ensure effective management and compliance.
- Headquarters Gurugram, India
- SectorsHealthcare
- Email••••••••
- Legal Name Vmg Pharmaceuticals Private Limited
- Date of Incorporation 17 Jul, 2008
- Jurisdiction Gurugram, Haryana, India
- Annual Revenue₹2.17 Cr
FY 2025 · -64% YoY
- Net Loss-₹1.63 Cr
FY 2025 · -75% margin
- EBITDA-₹1.48 Cr
FY 2025 · -68% margin
Associated legal entities of Vmg pharmaceuticals
Vmg pharmaceuticals operates through Vmg Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vmg Pharmaceuticals Private Limited CIN U24100HR2008PTC092142 | Active | 17 Jul 2008 | Gurugram, Haryana | ₹2.2 Cr | 3 | View details |
Products & Services of Vmg pharmaceuticals
Vmg pharmaceuticals offers a comprehensive portfolio of products and services, including Trientine Hydrochloride and ATGAM Sterile Solution.
Trientine Hydrochloride is manufactured for use in therapeutic applications.
ATGAM Sterile Solution is exported for medical purposes.
Board of directors of Vmg Pharmaceuticals Private Limited (Vmg pharmaceuticals)
Vmg Pharmaceuticals Private Limited is the primary company behind Vmg pharmaceuticals. The board of Vmg Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Jose Alejandro Murillo Campos, appointed in 2008. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jose Alejandro Murillo Campos DIN 02404954 | Director | 05 Nov 2008 | 17 yrs 11 mo | Vmg Pharmaceuticals Private Limited |
| Gauri Pandey DIN 08273004 | Director | 02 Nov 2018 | 7 yrs 11 mo | Vmg Pharmaceuticals Private Limited |
| Amita Rajesh DIN 01017504 | Additional Director | 31 Mar 2019 | 7 yrs 7 mo | Vmg Pharmaceuticals Private Limited |
People of Vmg pharmaceuticals
3 people are tracked at Vmg pharmaceuticals (3 in leadership).
| Name | Role | Group |
|---|---|---|
Rajesh Kumar | CEO | Leadership |
| Director | Leadership | |
| Director | Leadership |
Complete people profiles for Vmg pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vmg pharmaceuticals
Figures of Vmg Pharmaceuticals Private Limited, the primary company behind Vmg pharmaceuticals, for FY 2025. Revenue was ₹2.17 Cr (-64% year on year). Net loss was -₹1.63 Cr (-75% margin). EBITDA was -₹1.48 Cr (-68% margin). Revenue has grown at a compounded annual rate of -45% over three years and -24% over five years.
- ₹2.17 CrRevenue · FY 2025 · -64% YoY
- -₹1.63 CrNet loss · -75% margin
- -₹1.48 CrEBITDA · -68% margin
- ₹11.6 LakhPaid-up capital
- -45%Revenue CAGR, 3 years
- -24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vmg Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Vmg pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vmg pharmaceuticals
Vmg pharmaceuticals was founded in 2008.
Vmg pharmaceuticals is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
The primary company behind Vmg pharmaceuticals, Vmg Pharmaceuticals Private Limited, reported revenue of ₹2.17 Cr for FY 2025, down 64% year on year.
VMG Pharmaceuticals Pvt. Ltd. was established in May 2008 in New Delhi, India, as part of VMG Healthcare Products S.A., which was founded in 1998 and headquartered in Costa Rica. A wide range of pharmaceutical products is offered across various therapeutic segments, with a strong international presence maintained across multiple geographies. Strong logistics and regulatory systems are provided in India, supporting global operations. The company is involved in hiring for key roles to ensure effective management and compliance.
Vmg pharmaceuticals offers Trientine Hydrochloride and ATGAM Sterile Solution.
Vmg pharmaceuticals operates through Vmg Pharmaceuticals Private Limited.
The legal entities of Vmg pharmaceuticals currently have 3 directors, including Gauri Pandey, Amita Rajesh, Jose Alejandro Murillo Campos.